feisty
Early menopause is menopause that occurs before the age of 45. When it happens before 40, it's called premature ovarian insufficiency (POI), a term that replaced the older label "premature menopause" because the ovaries don't always stop functioning completely. About 1 in 100 women experience menopause before 40, and roughly 1 in 1,000 experience it before 30. Those numbers are small, but for the women living through it, the experience is often disorienting, medically complex, and under-discussed.
What makes menopause "early"?
The average age of natural menopause in Australia sits at around 51. Menopause is confirmed when a woman has gone 12 consecutive months without a period, with no other medical cause. Early menopause is confirmed by the same marker, just arriving before 45. POI, by contrast, doesn't always mean periods have stopped permanently. Some women with POI still have occasional cycles and, in rare cases, still conceive naturally. The distinction matters for diagnosis, treatment, and how a woman plans her life after the news.
The gap between early menopause and POI is more than semantic. Early menopause means the ovaries have finished. POI means they're working inconsistently. Both involve lower oestrogen than the body expects at that age, and that's where most of the health consequences originate.
What causes it?
In many cases, the cause is never identified. That's called idiopathic POI. For the cases where a cause is found, the main culprits include:
- Genetic factors: Turner syndrome and Fragile X premutation are the two most commonly identified genetic links. Women with a mother or sister who experienced early menopause are also at higher risk.
- Autoimmune conditions: The immune system attacks ovarian tissue in some women. Autoimmune thyroid disease and Addison's disease are sometimes found alongside POI.
- Medical treatments: Chemotherapy and pelvic radiation are well-established triggers. Surgical removal of the ovaries causes immediate menopause regardless of age.
- Infections: Rarely, viral infections including mumps have been linked to ovarian damage.
Smoking brings forward menopause by roughly 1 to 2 years in most studies, making it one of the few modifiable risk factors. Very low body weight and extreme endurance training have weaker but documented associations.
The symptoms nobody expects
Hot flushes and irregular periods get most of the attention, but early menopause produces a wider range of effects, particularly because the drop in oestrogen is happening in a body that hasn't had decades to prepare for it. Brain fog, joint pain, mood shifts, vaginal dryness, and disrupted sleep all show up. For a complete picture of what the body does during this transition, the menopause symptoms nobody warns you about covers the less-discussed effects in detail.
The cardiovascular and bone consequences are more serious in early menopause than in menopause at the typical age. Oestrogen plays a protective role in bone density and heart health. Losing it at 35 instead of 51 means 15 or more additional years of exposure to those risks. Women diagnosed with early menopause or POI face a higher risk of osteoporosis, cardiovascular disease, and cognitive decline than their peers who reach menopause at the average age.
How is it diagnosed?
Diagnosis starts with a blood test measuring follicle-stimulating hormone (FSH). In menopause, FSH rises significantly because the brain is signalling the ovaries to produce more eggs, and getting no response. A high FSH result (above 25 IU/L on two tests taken 4 to 6 weeks apart) combined with at least 4 months of irregular or absent periods in a woman under 40 points to POI. Anti-Mullerian hormone (AMH) and antral follicle count via ultrasound are also used to assess ovarian reserve.
One of the most consistent problems with early menopause diagnosis is delay. Women under 40 presenting with irregular periods are often told it's stress, polycystic ovary syndrome, or thyroid dysfunction before anyone checks FSH. Average diagnostic delay in published research is around 5 years from symptom onset to confirmed POI. That delay carries real health costs.
What the treatment evidence actually says
Hormone replacement therapy (HRT) is the primary treatment for early menopause and POI, and the evidence for it in this context is strong. Unlike HRT in women at or past the average menopausal age, where risk-benefit calculations are more nuanced, HRT in women with POI largely replaces what the body should still be making. The research on managing menopause consistently shows that women who don't replace oestrogen after early menopause face measurably worse cardiovascular and bone outcomes over time.
The standard recommendation is to continue HRT at least until the average age of natural menopause (around 51), at which point the risk-benefit assessment shifts to the same calculation as for any other menopausal woman. Stopping earlier, without clinical reason, removes protection the body still needs.
For women who can't or choose not to use HRT, the approach shifts to managing specific risks. Bone density protection through resistance training, calcium, and vitamin D becomes critical. So does cardiovascular health through diet, regular exercise, and not smoking. Evidence for non-hormonal symptom relief varies considerably by symptom, and it's worth understanding which natural approaches have real support. The natural menopause treatments that actually have evidence behind them breaks down where the research is solid and where it isn't.
Fertility after early menopause
Fertility is one of the most emotionally significant aspects of an early menopause diagnosis, and the picture is complicated. With complete early menopause, natural conception is very unlikely. With POI, spontaneous ovulation still happens in a meaningful minority of women, and around 5 to 10 per cent conceive naturally at some point after diagnosis. Those numbers shouldn't be used as a contraceptive plan, but they matter for how the diagnosis is framed.
Oocyte donation is the most reliable assisted reproduction option for women with POI. Embryo cryopreservation before cancer treatment is now standard practice at most oncology centres in Australia, offered to women who receive a cancer diagnosis before their ovaries are affected by treatment. Ovarian tissue freezing is also available at some specialist centres, though it remains less established.
The mental health dimension
An early menopause diagnosis hits differently at 34 than at 52. The loss of fertility, the identity shift, and the sense of a body acting against expectations can produce grief that clinical treatment guidelines don't always address directly. Depression and anxiety are more prevalent in women with POI than in age-matched women, and they're not simply a symptom of low oestrogen. They're a response to a genuinely difficult life event.
Peer support matters here. Organisations including Jean Hailes for Women's Health offer POI-specific resources and can connect women with specialist services and peer networks. Access to a specialist with experience in POI, rather than a general GP managing the diagnosis, also makes a measurable difference to outcomes and to how well women feel supported.
Early menopause is not a rare edge case. It's an under-recognised condition that affects enough women to warrant clearer diagnostic pathways, faster specialist access, and far more open conversation than it currently gets.